# Asthma Exacerbation Study

> **NCT01086384** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2020 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate/GW642444
- **DRUG:** Fluticasone furoate

## Key facts

- **NCT ID:** NCT01086384
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-22
- **Primary completion:** 2011-09-01
- **Final completion:** 2011-09-15
- **Target enrollment:** 2020 (ACTUAL)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086384, "Asthma Exacerbation Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01086384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*